Stay updated with breaking news from Umer Raffat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer Inc. projected about $15 billion in revenue this year from the Covid-19 vaccine it developed with BioNTech SE, but the shares fell amid questions about the durability of the market for the shot.
Pfizer, the first company to get U.S. emergency use authorization for a COVID-19 vaccine, swung to a small profit in the fourth-quarter as it started shipping vaccines globally. The drugmaker expects roughly $15 billion in revenue this year from the vaccine, which won emergency clearance in mid-December from U.S. regulators and continues to rack up approvals across the globe. The two-dose vaccine is about 95% effective and is one of only a few vaccines available to check the global pandemic. Rising medicine sales helped offset big increases in spending on research and production as the New ...
Pfizer Projects $15 Billion in 2021 Sales of Covid Vaccine Bloomberg 2/2/2021 Riley Griffin (Bloomberg) -- Pfizer Inc. projected about $15 billion in revenue this year from the Covid-19 vaccine it developed with BioNTech SE, but the shares fell amid questions about the durability of the market for the shot. Company officials led by Chief Executive Albert Bourla said on a conference call that the vaccine looks capable of taking on new variants, its price may increase and new products using its messenger RNA technology are on the way. Still, the shares fell as much as 4.3% and...
NewsSportsTicketLifestyleOpinionUSA TODAYObituariesE-EditionLegals CORPORATE REPORT: UPS, Pfizer surpass Wall Street expectations; Tesla agrees to recall Oil giants Exxon and BP report staggering losses for 2020 as the pandemic crushes energy demand and undercuts oil prices. Sarasota Herald-Tribune A surge in online shopping helped United Parcel Service (UPS) post record revenue during the last three months of 2020, the company said on Tuesday. Its stock rose nearly 5% in early trading. UPS and other delivery companies have seen demand spike as more people shop online during the pandemic....
MONEYWEB app instead? Pfizer forecasts R225bn in Covid vaccine sales for 2021 And may generate additional revenue from a booster shot being developed to combat the âSouth Africanâ variant. By Riley Griffin, Bloomberg 2 Feb 2021 20:13 The pharma giant spent more than $9bn on R&D in 2020. Image: Christinne Muschi, Bloomberg Pfizer Inc said it expects about $15 billion (close to R225 billion) in revenue this year from the Covid-19 vaccine it developed with BioNTech SE, a sign of returns to come from the industryâs pandemic response efforts. The vaccine projection primaril...